2014
DOI: 10.1002/pbc.25010
|View full text |Cite
|
Sign up to set email alerts
|

Bone mineral density among long‐term survivors of childhood acute lymphoblastic leukemia: Results from the St. Jude Lifetime Cohort Study

Abstract: Background The prevalence of low bone mineral density (BMD) in adult survivors of childhood acute lymphoblastic leukemia (ALL), and the degree of recovery or decline, are not well elucidated. Procedure Study subjects (age ≥ 18 years and ≥ 10 years post-diagnosis) participated in an institutional follow-up protocol and risk-based clinical evaluation based on Children’s Oncology Group guidelines. Trabecular volumetric BMD was ascertained using quantitative computed tomography, reported as age- and sex-specific… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

10
102
1
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 106 publications
(115 citation statements)
references
References 26 publications
10
102
1
2
Order By: Relevance
“…Prolonged treatment with high-dose glucocorticoids in children with ALL may also result in acute complications such as vertebral body compression fractures and avascular necrosis of the bones (165,166). Skeletal recovery was noted to begin shortly after the completion of ALL treatments, but BMD may remain abnormally low for age over several years depending on a variety of factors such as the severity of the deficit at baseline, the presence of other chronic health issues and lifestyle variables (165,166,167 (179,180). Changes in bone remodeling and secondary hyperparathyroidism have been recently described in patients treated with TKI (8).…”
Section: Prevalence and Risk Factorsmentioning
confidence: 99%
“…Prolonged treatment with high-dose glucocorticoids in children with ALL may also result in acute complications such as vertebral body compression fractures and avascular necrosis of the bones (165,166). Skeletal recovery was noted to begin shortly after the completion of ALL treatments, but BMD may remain abnormally low for age over several years depending on a variety of factors such as the severity of the deficit at baseline, the presence of other chronic health issues and lifestyle variables (165,166,167 (179,180). Changes in bone remodeling and secondary hyperparathyroidism have been recently described in patients treated with TKI (8).…”
Section: Prevalence and Risk Factorsmentioning
confidence: 99%
“…As an increasing number of cancer survivors reaches adulthood, there may be consequences of the treatment, including adiposity, metabolic syndrome traits [2][3][4][5][6][7][8][9] and occasionally low bone mass [10][11][12][13][14][15][16][17][18], which is a condition not totally understood, so far.…”
Section: Introductionmentioning
confidence: 99%
“…Cancer survivors, particularly ALL patients, are part of one of these important groups and there are several important concerns regarding their bone heath [10][11][12][13][14][15][16][17][18][19]. Low bone mass has been observed in all phases of the disease: at diagnosis, during treatment, and throughout the post-treatment period for as long as 20 years [21].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, various inflammatory cytokines like tumor necrosis factor alpha (TNF-a), interleukins are released and results in bone erosion [8]. Furthermore, the drugs used for treatment mainly steroids, methotrexate and radiotherapy cause osteoporosis in ALL [6,10]. The radiographic changes described in ALL include osteopenia, metaphyseal bands, periosteal new bone formation, geographic osteolysis, osteosclerosis, mixed osteolysis-sclerosis and permeative destruction [6,11].At diagnosis, vertebral fracture is seen 16 % of children with ALL.…”
Section: Discussionmentioning
confidence: 99%